Evidence supporting the use of: Vitamin E (alpha-tocopherol)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (specifically alpha-tocopherol) has been studied as a potential treatment or supportive therapy for dementia, particularly Alzheimer's disease, due to its antioxidant properties. The rationale is that oxidative stress may contribute to neurodegeneration, so antioxidants like vitamin E could theoretically protect neuronal cells. Several randomized controlled trials have investigated vitamin E supplementation in people with mild to moderate Alzheimer's disease. Notably, the 1997 Sano et al. study (NEJM) found that high-dose vitamin E (2,000 IU/day) modestly delayed functional decline compared to placebo. However, subsequent research has produced mixed results. Some studies found no significant cognitive benefit, while others raised concerns about potential harm at high doses, including increased all-cause mortality in some meta-analyses. Systematic reviews and clinical guidelines generally conclude that vitamin E may have a small effect in slowing functional decline in Alzheimer's, but not in improving cognition or preventing dementia. Major organizations such as the American Academy of Neurology and the Alzheimer's Association do not recommend vitamin E as a routine therapy for dementia, due to limited efficacy and potential safety concerns. In summary, there is some scientific evidence for vitamin E in dementia, but it is weak and inconsistent, resulting in only modest support for its use.

More about Vitamin E (alpha-tocopherol)
More about Dementia

Products containing Vitamin E (alpha-tocopherol)

We currently have no products on Vitabase that contain this ingredient.